Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $15.13 in the prior trading day, Takeda Pharmaceutical Co ADR (NYSE: TAK) closed at $15.16, up 0.20%. In other words, the price has increased by $0.20 from its previous closing price. On the day, 0.93 million shares were traded. TAK stock price reached its highest trading level at $15.178 during the session, while it also had its lowest trading level at $15.09.
Ratios:
Our goal is to gain a better understanding of TAK by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.29 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.49. For the most recent quarter (mrq), Quick Ratio is recorded 0.72 and its Current Ratio is at 1.31. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.63.
On July 19, 2022, Cowen Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $21 to $24.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 23 ’24 when Giles Richard Platford bought 19,073 shares for $14.94 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TAK now has a Market Capitalization of 48273231872 and an Enterprise Value of 4962151563264. As of this moment, Takeda’s Price-to-Earnings (P/E) ratio for their current fiscal year is 35.65, and their Forward P/E ratio for the next fiscal year is 29.74. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.32. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.59 while its Price-to-Book (P/B) ratio in mrq is 1.02. Its current Enterprise Value per Revenue stands at 1.084 whereas that against EBITDA is 3.924.
Stock Price History:
The Beta on a monthly basis for TAK is 0.41, which has changed by 0.052047133 over the last 52 weeks, in comparison to a change of 0.08190584 over the same period for the S&P500. Over the past 52 weeks, TAK has reached a high of $15.24, while it has fallen to a 52-week low of $12.57. The 50-Day Moving Average of the stock is 8.98%, while the 200-Day Moving Average is calculated to be 9.39%.
Shares Statistics:
The stock has traded on average 1.76M shares per day over the past 3-months and 1592840 shares per day over the last 10 days, according to various share statistics. A total of 3.17B shares are outstanding, with a floating share count of 3.17B. Insiders hold about 0.02% of the company’s shares, while institutions hold 5.04% stake in the company. Shares short for TAK as of 1740700800 were 4314438 with a Short Ratio of 2.45, compared to 1738281600 on 3735982. Therefore, it implies a Short% of Shares Outstanding of 4314438 and a Short% of Float of 0.13999999999999999.
Dividends & Splits
In the trailing 12 months, TAK’s forward annual dividend rate was 192.0, compared to 0.62 this year. Against a Trailing Annual Dividend Yield of 12.69002The stock’s 5-year Average Dividend Yield is 4.71.
